Intrexon | XON - Należności Handlowe





Należności Handlowe Zmiana Data
Agenus USD 22.44M 1.14M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 13.37M 55.86M 2025-12
MannKind USD 38.37M 20.98M 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Thermo Fisher Scientific USD 8.9B 11M 2025-12
Veracyte USD 44.66M 3.17M 2025-12
Xencor USD 29.3M 7.49M 2025-12